Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.14170 http://scihub22266oqcxt.onion/10.1111/dth.14170 32779280!7436694!32779280     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dermatol+Ther 2020 ; 33 (6): e14170 Nephropedia Template TP {{tp|p=32779280|t=2020. Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study |pdf=|usr=}}{{32779280}} gab.com Text Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32779280 #FOAvip A previous study has defined the maculopapular subtype of manifestations of COVID-19. The objective of our study was to describe and classify maculopapular eruptions associated with COVI-19. We carried out a subanalysis of the maculopapular cases found in the previous cross-sectional study. Using a consensus, we defined seven clinical patterns. We described patient demographics, the therapy received by the patient and the characteristics of each pattern. Consensus lead to the description of seven major maculopapular patterns: morbilliform (45.5%), other maculopapular (20.0%), purpuric (14.2%), erythema multiforme-like (9.7%), pytiriasis rosea-like (5.7%), erythema elevatum diutinum-like (2.3%), and perifollicular (2.3%). In most cases, maculopapular eruptions were coincident (61.9%) or subsequent (34.1%) to the onset of other COVID-19 manifestations. The most frequent were cough (76%), dyspnea (72%), fever (88%), and astenia (62%). Hospital admission due to pneumonia was frequent (61%). Drug intake was frequent (78%). Laboratory alterations associated with maculo-papular eruptions were high C-reactive protein, high D-Dimer, lymphopenia, high ferritin, high LDH, and high IL-6. The main limitation of our study was the impossibility to define the cause-effect relationship of each pattern. In conclusion, we provide a description of the cutaneous maculopapular manifestations associated with COVID-19. The cutaneous manifestations of COVID-19 are wide-ranging and can mimic other dermatoses. Twit Text FOAVip Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32779280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32779280 #FOAvip English Wikipedia <ref>{{Cite pmid|32779280}}</ref> Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study #MMPMID32779280 Catala A; Galvan-Casas C; Carretero-Hernandez G; Rodriguez-Jimenez P; Fernandez-Nieto D; Rodriguez-Villa A; Navarro-Fernandez I; Ruiz-Villaverde R; Falkenhain-Lopez D; Llamas-Velasco M; Carnero-Gonzalez L; Garcia-Gavin J; Baniandres O; Gonzalez-Cruz C; Morillas-Lahuerta V; Cubiro X; Figueras I; Selda-Enriquez G; Fusta-Novell X; Roncero-Riesco M; Burgos-Blasco P; Romani J; Sola-Ortigosa J; Garcia-Doval I Dermatol Ther 2020[Nov]; 33 (6): e14170 PMID32779280show ga A previous study has defined the maculopapular subtype of manifestations of COVID-19. The objective of our study was to describe and classify maculopapular eruptions associated with COVI-19. We carried out a subanalysis of the maculopapular cases found in the previous cross-sectional study. Using a consensus, we defined seven clinical patterns. We described patient demographics, the therapy received by the patient and the characteristics of each pattern. Consensus lead to the description of seven major maculopapular patterns: morbilliform (45.5%), other maculopapular (20.0%), purpuric (14.2%), erythema multiforme-like (9.7%), pytiriasis rosea-like (5.7%), erythema elevatum diutinum-like (2.3%), and perifollicular (2.3%). In most cases, maculopapular eruptions were coincident (61.9%) or subsequent (34.1%) to the onset of other COVID-19 manifestations. The most frequent were cough (76%), dyspnea (72%), fever (88%), and astenia (62%). Hospital admission due to pneumonia was frequent (61%). Drug intake was frequent (78%). Laboratory alterations associated with maculo-papular eruptions were high C-reactive protein, high D-Dimer, lymphopenia, high ferritin, high LDH, and high IL-6. The main limitation of our study was the impossibility to define the cause-effect relationship of each pattern. In conclusion, we provide a description of the cutaneous maculopapular manifestations associated with COVID-19. The cutaneous manifestations of COVID-19 are wide-ranging and can mimic other dermatoses. |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/complications/diagnosis/*virology[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Host-Pathogen Interactions[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Risk Factors[MESH] |SARS-CoV-2/drug effects/*pathogenicity[MESH] |Skin Diseases, Viral/diagnosis/*virology[MESH] |Skin/pathology/*virology[MESH] |Spain[MESH]Maculopapular eruptions associated to COVID-19: A subanalysis of the C(epmc).pdf DeepDyve Pubget Overpricing